-starting and ending dates of the study are lacking -there is no mention about the clinical assesment during the follow-up: only clinical examination or also imaging? -including criteria are not so clear: please specify better. 1.only patients with contaminated fields or all? 2.only planned intervention or even emergency surgery for incarcerated hernias? 3. "The appropriateness of a biologic mesh will be determined via consensus between the two surgeons": thi is not clear, please describe better. 4. only incisional ventral hernias or even groin hernias? 1) You reference a study from 1998 stating that using synthetic mesh in a contaminated field results in a marked increase in recurrence and mesh infection. There have been several studies that stand against that assumption since then. In our study, we found that using a synthetic mesh is not inferior to a biologic mesh in those regards.
REVIEWER
This is an important observation on the current state of the literature on mesh use in abdominal wall reconstruction. Thank you for including your reference. We have updated the 'Introduction' section (page 3, paragraph 2) as well as the 'Conclusion' section (page 8, paragraph 1) of the manuscript to recognize this ongoing debate. At this point in time, biologic mesh continues to be used regularly in abdominal wall reconstruction. While this debate is ongoing, we feel there continues to be value in comparing different types of biologic mesh products. Once an optimal biologic mesh is identified, it could them be compared to a preferred synthetic mesh in a randomized controlled trial to help define this important debate.
2 and 3. You have to define what appropriateness to using a biologic mesh is. Mention specific criteria that need to be met. You have to define the hernia size and complexity of the procedure. A simple port-site hernia qualifies as an incisional hernia and pretty much can be treated primarily as opposed to a midline incisional hernia requiring myofascial release.
Specific criteria have been added to the 'eligibility criteria' section (page 5, paragraph 2). We have not made any strict size criteria, although, based on the above eligibility criteria, minor port size hernias would not be considered eligible for the trial. Hernia dimensions will be recorded and reported as part of the trial results.
4. It will likely be more accurate to employ a single technique for hernia repair. ex: myofascial release with mesh in retrorectus space.
Thank you again for this important observation. As you have described, the majority of repairs will consist of myofascial release as well as mesh in the retrorectus space. There will likely be some variability based on hernia-specific factors and we have therefore chosen not to specify the exact method of repair. The details of each repair will be recorded in detail and described in the trial results. A subgroup analysis may be required based on the variability in repair methods.
REVIEWER 2
Dr. Leblanc, Thank you for your review and comment.
1) This will take a while to do? How quickly can you enroll 90 patients?
More than thirty-five complex abdominal wall reconstructions per year are performed at the trial centre. We expect to capture all of these patients within the trial and therefore should meet our required sample size within 2-3 years (updated page 8, paragraph 1).
REVIEWER 3
Dr. Ceresoli, Thank you for your review and these important clarifications.
1) Starting and ending dates of the study are lacking
The study start date is Oct 26, 2017. The expected completion date will be within 2-3 years of the study start date. (page 8, paragraph 1)
2) There is no mention about the clinical assesment during the follow-up: only clinical examination or also imaging?
Inpatient assessments will include daily physical examinations, bloodwork and other tests as clinically indicated. Similarly, outpatient followup will consist of clinical history and physical examination by the operating surgeon and other tests as required. Any suspected recurrence will be confirmed with a CT scan. This is outlines in the 'Outcomes' section (page 7, paragraph 1) 3-6) Including criteria are not so clear: please specify better. only patients with contaminated fields or all? only planned intervention or even emergency surgery for incarcerated hernias? only incisional ventral hernias or even groin hernias?
Specific criteria have been added to the 'eligibility criteria' section (page 5, paragraph 2).
REVIEWER 4
Dr. Köckerling, Thank you for your thoughtful review and expertise.
Your paper (Köckerling et al 2018, Hernia, 22:249-269) provides an important update on the expert consensus regarding the use of biologic mesh products in abdominal wall reconstruction. The results of your paper were not available during the design of our trial or the preparation of the study protocol manuscript. We have updated the 'Introduction' to reflect this updated information. As mentioned earlier in our response to Dr. Chamieh's comments, biologic mesh continues to be used regularly in abdominal wall reconstruction. While this debate is ongoing, we feel there continues to be value in comparing different types of biologic mesh products in a randomized trial setting. Once an optimal biologic mesh is identified, it could them be compared to a preferred synthetic mesh in a randomized controlled trial to help define this important debate.
